XML 13 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenues:    
Product sales $ 33,161 $ 51,757
License revenue 132 750
Total revenues 33,293 52,507
Operating expenses:    
Cost of products 6,592 3,902
Research and development expenses 9,951 7,206
Selling, general and administrative expenses 24,487 11,812
Intangible asset amortization 1,767 564
Loss (gain) - changes in fair value of related party contingent consideration 2,968 (6,971)
Restructuring costs 153 2,653
Total operating expenses 45,918 19,166
Operating (loss) income (12,625) 33,341
Investment income and other income (expense), net 54 821
Interest expense, net (1,597) (263)
Other (expense) income - changes in fair value of related party payable (395) 550
(Loss) income before income taxes (14,563) 34,449
Income tax (benefit) provision (2,327) 8,539
Net (loss) income $ (12,236) $ 25,910
Net income (loss) per share - basic (in dollars per share) $ (0.32) $ 0.63
Net income (loss) per share - diluted (in dollars per share) $ (0.32) $ 0.61
Weighted average number of shares outstanding - basic (in shares) 38,559 41,374
Weighted average number of shares outstanding - diluted (in shares) 38,559 42,810